Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.
<h4>Introduction</h4>Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections wit...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/742b254d266341d0acbdb33576c473fa |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:742b254d266341d0acbdb33576c473fa |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:742b254d266341d0acbdb33576c473fa2021-12-02T20:17:05ZIncreased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.1932-620310.1371/journal.pone.0258513https://doaj.org/article/742b254d266341d0acbdb33576c473fa2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258513https://doaj.org/toc/1932-6203<h4>Introduction</h4>Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC.<h4>Materials and methods</h4>Using linked individual-level data from national registries, we conducted a cohort study on laboratory-confirmed cases of SARS-CoV-2 in Norway diagnosed between 28 December 2020 and 2 May 2021. Variants were identified based on whole genome sequencing, partial sequencing by Sanger sequencing or PCR screening for selected targets. The outcome was hospitalisation or ICU admission. We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable binomial regression to examine the association between SARS-CoV-2 variants B.1.1.7 and B.1.351 with i) hospital admission and ii) ICU admission compared to non-VOC.<h4>Results</h4>We included 23,169 cases of B.1.1.7, 548 B.1.351 and 4,584 non-VOC. Overall, 1,017 cases were hospitalised (3.6%) and 206 admitted to ICU (0.7%). B.1.1.7 was associated with a 1.9-fold increased risk of hospitalisation (aRR 95%CI 1.6-2.3) and a 1.8-fold increased risk of ICU admission (aRR 95%CI 1.2-2.8) compared to non-VOC. Among hospitalised cases, no difference was found in the risk of ICU admission between B.1.1.7 and non-VOC. B.1.351 was associated with a 2.4-fold increased risk of hospitalisation (aRR 95%CI 1.7-3.3) and a 2.7-fold increased risk of ICU admission (aRR 95%CI 1.2-6.5) compared to non-VOC.<h4>Discussion</h4>Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity.Lamprini VenetiElina SeppäläMargrethe Larsdatter StormBeatriz Valcarcel SalamancaEirik Alnes BuanesNina AasandUmaer NaseerKaroline BragstadOlav HungnesHåkon BøåsReidar KvåleKaran GolestaniSiri FeruglioLine VoldKarin NygårdRobert WhittakerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258513 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Lamprini Veneti Elina Seppälä Margrethe Larsdatter Storm Beatriz Valcarcel Salamanca Eirik Alnes Buanes Nina Aasand Umaer Naseer Karoline Bragstad Olav Hungnes Håkon Bøås Reidar Kvåle Karan Golestani Siri Feruglio Line Vold Karin Nygård Robert Whittaker Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| description |
<h4>Introduction</h4>Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC.<h4>Materials and methods</h4>Using linked individual-level data from national registries, we conducted a cohort study on laboratory-confirmed cases of SARS-CoV-2 in Norway diagnosed between 28 December 2020 and 2 May 2021. Variants were identified based on whole genome sequencing, partial sequencing by Sanger sequencing or PCR screening for selected targets. The outcome was hospitalisation or ICU admission. We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable binomial regression to examine the association between SARS-CoV-2 variants B.1.1.7 and B.1.351 with i) hospital admission and ii) ICU admission compared to non-VOC.<h4>Results</h4>We included 23,169 cases of B.1.1.7, 548 B.1.351 and 4,584 non-VOC. Overall, 1,017 cases were hospitalised (3.6%) and 206 admitted to ICU (0.7%). B.1.1.7 was associated with a 1.9-fold increased risk of hospitalisation (aRR 95%CI 1.6-2.3) and a 1.8-fold increased risk of ICU admission (aRR 95%CI 1.2-2.8) compared to non-VOC. Among hospitalised cases, no difference was found in the risk of ICU admission between B.1.1.7 and non-VOC. B.1.351 was associated with a 2.4-fold increased risk of hospitalisation (aRR 95%CI 1.7-3.3) and a 2.7-fold increased risk of ICU admission (aRR 95%CI 1.2-6.5) compared to non-VOC.<h4>Discussion</h4>Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity. |
| format |
article |
| author |
Lamprini Veneti Elina Seppälä Margrethe Larsdatter Storm Beatriz Valcarcel Salamanca Eirik Alnes Buanes Nina Aasand Umaer Naseer Karoline Bragstad Olav Hungnes Håkon Bøås Reidar Kvåle Karan Golestani Siri Feruglio Line Vold Karin Nygård Robert Whittaker |
| author_facet |
Lamprini Veneti Elina Seppälä Margrethe Larsdatter Storm Beatriz Valcarcel Salamanca Eirik Alnes Buanes Nina Aasand Umaer Naseer Karoline Bragstad Olav Hungnes Håkon Bøås Reidar Kvåle Karan Golestani Siri Feruglio Line Vold Karin Nygård Robert Whittaker |
| author_sort |
Lamprini Veneti |
| title |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| title_short |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| title_full |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| title_fullStr |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| title_full_unstemmed |
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021. |
| title_sort |
increased risk of hospitalisation and intensive care admission associated with reported cases of sars-cov-2 variants b.1.1.7 and b.1.351 in norway, december 2020 -may 2021. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/742b254d266341d0acbdb33576c473fa |
| work_keys_str_mv |
AT lampriniveneti increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT elinaseppala increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT margrethelarsdatterstorm increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT beatrizvalcarcelsalamanca increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT eirikalnesbuanes increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT ninaaasand increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT umaernaseer increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT karolinebragstad increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT olavhungnes increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT hakonbøas increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT reidarkvale increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT karangolestani increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT siriferuglio increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT linevold increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT karinnygard increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 AT robertwhittaker increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021 |
| _version_ |
1718374411509170176 |